Showing results (11-20 of 496) with videos related to

Sort By:
Pageof 50
Cancer|July 15, 2009
Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention TrialZhihong Gong, Alan R Kristal, Jeannette M Schenk, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 13, 2018
Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by FinasterideJames Y Dai, Michael LeBlanc, Phyllis J Goodman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approachMary W Redman, Catherine M Tangen, Phyllis J Goodman, et al.
The Journal of Urology|May 16, 2006
The prostate cancer prevention trial: design, biases and interpretation of study resultsPhyllis J Goodman, Ian M Thompson, Catherine M Tangen, et al.
Clinical Prostate Cancer|March 30, 2004
Ten-year survival in patients with metastatic prostate cancerCatherine M Tangen, James R Faulkner, E David Crawford, et al.
Cancer|May 31, 2013
The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcomeAndrew J Vickers, Daniel D Sjoberg, Donna P Ankerst, et al.
JAMA|January 18, 2006
Erectile dysfunction and subsequent cardiovascular diseaseIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 9, 2022
Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention TrialJeannette M Schenk, Cathee Till, Marian L Neuhouser, et al.
The Prostate|May 29, 2009
Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention TrialJeannette M Schenk, Alan R Kristal, Marian L Neuhouser, et al.
Pageof 50